MGX

Metagenomi, Inc. (MGX) is a pioneering biotechnology firm headquartered in Emeryville, California, that focuses on developing cutting-edge gene editing therapies through its unique metagenomics-derived toolkit. The company is committed to creating transformative therapeutics that address critical unmet medical needs across various indications. By harnessing advanced technologies and fostering strategic partnerships, Metagenomi is strategically positioned to lead innovations in precision medicine, with the goal of significantly impacting the treatment landscape in the biopharmaceutical sector.